Metavia Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.43

-0.06 (-4.03%)

As of Jun 30, 10:57 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +455.9% upside

Low Target $5.82

Average Target $7.95

High Target $9.13

Current Price $1.43

Current
$1.43

Target
$7.95

$5.82 $7.95 avg $9.13

Scenario Analysis

Bear Case

$5.82

307.0%

Low target

Base Case

$7.95

+455.9%

Avg target

Bull Case

$9.13

+538.5%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$19.03

-92.5% from high

52-Week Low

$0.97

+48.0% from low

Target vs 52W High

$7.95

-58.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%